Clinical Trials Browser

Hypoxia, Uterine Cervical Neoplasms

NCT01181375 2026-03-05

Predictive Assays In Cervix Cancer

Phase NA Active not recruiting

500 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT06475261 2025-03-07

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Recruiting

50 enrolled

GenitourinaryGynecologic

Hypoxia, Ovarian Neoplasms, Acute Kidney Injury

NCT06353061 2025-01-14

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Phase 2 Unknown

51 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT06041555 2024-02-20

ISRAR

Recruiting

600 enrolled

CNSGenitourinaryGynecologicHead & Neck

Hypoxia, Uterine Cervical Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms

NCT03466034 2020-01-29

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Terminated

5 enrolled

Gynecologic

Hypoxia, Adenocarcinoma, Mucinous, Endometrial Neoplasms

NCT02233387 2019-03-08

HX4-cervix

Phase 2 Terminated

4 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT00388687 2006-10-17

Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer

Unknown

25 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

Clinical Trials

Bio-CHECC

Predictive Assays In Cervix Cancer

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

ISRAR

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

HX4-cervix

Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer